Are NSAIDs and selective cyclo-oxygenase 2 inhibitors associated with increased risk of myocardial infarction?

Nature Clinical Practice Rheumatology

Volumn 4, Issue 4, 2008, Pages 182-183

  Abramson, Steven B ^a   Greenberg, Jeffrey D ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; LACTONE; PYRAZOLE DERIVATIVE; SULFONAMIDE; SULFONE;

ARTHRITIS; ARTICLE; CARDIOVASCULAR RISK; CHRONIC PAIN; CLINICAL TRIAL; COLON ADENOMA; DRUG SAFETY; GASTROINTESTINAL DISEASE; HEART INFARCTION; HEART PROTECTION; HUMAN; PRIORITY JOURNAL; RHEUMATIC DISEASE; RISK BENEFIT ANALYSIS; CHEMICALLY INDUCED DISORDER; RISK ASSESSMENT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2 INHIBITORS; HUMANS; LACTONES; MYOCARDIAL INFARCTION; PYRAZOLES; RISK ASSESSMENT; SULFONAMIDES; SULFONES;

EID: 45549106336     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0763     Document Type: Article

References (5)

1. Kearney PM et al. (2006) Do selective cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 332: 1302-1308
2. McGettigan P and Henry D (2006) Cardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 296: 1633-1644
3. Singh G et al. (2006) Risk of acute myocardial infarction withr nonselective non-steroidal anti-inflammatory drugs: A meta-analysis. Arthritis Res Ther 8: R153
4. Catella-Lawson F et al. (2001) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345: 1809-1817
5. MacDonald TM and Wei L (2003) Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 361: 573-574